U.S. markets close in 2 hours 2 minutes

Lyell Immunopharma, Inc. (LYEL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.0500+0.1400 (+3.58%)
As of 01:58PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Gravestone (Bullish)

Gravestone (Bullish)

Previous Close3.9100
Bid4.0200 x 1000
Ask4.0400 x 1100
Day's Range3.8600 - 4.1600
52 Week Range3.8600 - 19.8400
Avg. Volume1,307,516
Market Cap996.847M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.8410
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est17.33
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for LYEL

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Lyell Immunopharma, Inc.
    Technical Assessment: Bearish in the Intermediate-TermVolatility in West Texas Intermediate (WTI) crude oil has started to shrink a bit, with the recent range between the high $90s and $110 and with WTI currently sitting at $105/barrel. After going parabolic in March and reaching $130, crude oil pulled back to $93.50, rallied back to $116.65, and fell to an intraday low of $93 on April 11 before rallying back above $107. It is still possible that WTI is tracing out symmetrical triangle, although the past breakout attempt in early May failed.
    Fair Value
    Economic Moat
    5 days agoArgus Research
View more